Navigation Links
Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10
Date:9/3/2013

sttherapeutics.com.

Mast Therapeutics™ and the corporate logo are trademarks of Mast Therapeutics, Inc.

Forward Looking Statements
Mast Therapeutics cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on the Company's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the Company's development plans for MST-188 in acute limb ischemia, including the timing of initiation of the planned phase 2 study.  Among the factors that could cause or contribute to material differences between the Company's actual results and the expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: delays in the commencement of clinical studies, including as a result of difficulties in obtaining regulatory agency agreement on clinical development plans or clinical study design, opening trial sites, enrolling study subjects and manufacturing sufficient quantities of clinical trial material; the potential for institutional review boards or the FDA or other regulatory agencies to require additional nonclinical or clinical studies prior to initiation of a planned clinical study; and other risks and uncertainties more fully described in the Company's press releases and periodic filings with the Securities and Exchange Commission. The Company's public filings with the Securities and Exchange Commission are available at www.sec.gov.

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. Mast Therapeutics does not intend to revise or update any forward-looking statement set forth in this press release to reflect events or circumstances arising after the date hereof, except as may be required by law.

(Logo:

SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... CASTLE ROCK, Colo. , Aug. 28, 2014 /PRNewswire/ ... diagnostic company focused on obtaining FDA clearance for ... a rapid blood test for aiding in identifying children, ... who are at low risk for appendicitis, today announced ... Rodman & Renshaw 16 th Annual Global Investment ...
(Date:8/28/2014)... DIEGO , Aug. 28, 2014 Telik, ... development company that merged with MabVax Therapeutics, Inc. ... made significant progress related to the development of ... antibody was recovered using the Company,s internally developed ... the potential for multiple antibody based therapeutic and ...
(Date:8/28/2014)... DUBLIN, Ohio , Aug. 28, 2014 /PRNewswire/ ... rising competition in generics are adding pressure to ... internal resources. Company resources continue to shrink and ... complex. This has led companies to look for ... to commercialization and for keeping approved products on ...
Breaking Medicine Technology:Venaxis to Present at September Investor Conferences 2Venaxis to Present at September Investor Conferences 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 44 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4
(Date:8/29/2014)... VA (PRWEB) August 29, 2014 ... release of Clinical Trials Magnifier Weekly. , Clinical Trial ... the world every week and reports all the fresh ... FDAnews is able to extract just the information readers ... and drill down using links in the newsletter to ...
(Date:8/29/2014)... 2014 And the results are in! ... Caicos Islands, is voted a favorite with tourists and travelers ... the World in the Travelers' Choice Awards on the popular ... all across the globe pick their favorites, and the Turks ... multiple categories. , The Venetian on Grace Bay ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Recent ... have suggested that Americans today are working longer hours ... overworked and overstressed. APEC Water believes that drinking lots ... a Labor Day Sale on their most popular and ... and healthy. From now until 9/2/2014, customers can save ...
(Date:8/29/2014)... Farms, MI (PRWEB) August 29, 2014 ... structured data (relational tables) or unstructured data (document stores). ... while NoSQL products have basically managed the wide assortment ... only way to work with Big Data is with ... to solve the various aspects of all Big Data ...
(Date:8/29/2014)... Two Kelowna dentists are putting out ... a container filled with classroom materials, clinic supplies and even ... , “I don’t think words can describe ... Matson-Visscher. She and her husband, Dr. Jonathan Visscher, both partners ... part of New Reality International’s (NRI) mission to build and ...
Breaking Medicine News(10 mins):Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 2Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 3Health News:FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data 4Health News:Relax this Labor Day Weekend with Great Savings on Easy-Install, Do-It-Yourself Drinking and Whole House Water Filters 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 2Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 3
... HealthDay Reporter , TUESDAY, July 19 (HealthDay News) -- ... cancer are undergoing chemotherapy may help prevent early menopause and ... July 20 issue of the Journal of the American ... hormone triptorelin when a patient is undergoing chemotherapy helped prevent ...
... , TUESDAY, July 19 (HealthDay News) -- The antidepressants ... provide no appreciable relief, and may raise the ... "The two classes of antidepressants most likely ... no more effective than placebo," the study authors said. ...
... July, 2011 The Research4Life partners today announced two ... case study competition on how HINARI, AGORA, and/or OARE ... a pediatrician from Nepal and Mr. Mulugeta Bayisa, a ... over 60 entries to the competition held in celebration ...
... Radiation Oncology (ASTRO) has named its 2011 class of ... designation at a ceremony during the Society,s 53rd Annual ... Beach Convention Center in Miami Beach, Fla. , "ASTRO ... members of the radiation oncology community and receiving this ...
... a part of its new initiative, Expanding Access to Opioid ... Europe and Central Asia (EECA), the International AIDS Society (IAS) ... in partnership with the Ukrainian Institute on Public Health Policy ... 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS ...
... HILL, N.C. Women who have breastfeeding difficulties in ... likely to suffer postpartum depression two months later compared ... women with breastfeeding difficulties should be screened for depressive ... the University of North Carolina at Chapel Hill. ...
Cached Medicine News:Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 2Health News:Drug May Prevent Chemo-Linked Menopause in Breast Cancer Patients 3Health News:Two Antidepressants Given to Dementia Patients Ineffective: Study 2Health News:Joint winners announced in Research4life global case study competition 2Health News:Joint winners announced in Research4life global case study competition 3Health News:ASTRO announces 2011 Fellows class 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 2Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 3Health News:International AIDS Society to launch Virtual Media Centre in July to support opioid substitution therapy in Eastern Europe and Central Asia 4Health News:Mothers with breastfeeding difficulties more likely to suffer postpartum depression 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: